Literature DB >> 2681258

Isolation, acid proteinase secretion, and experimental pathogenicity of Candida parapsilosis from outpatients with vaginitis.

F De Bernardis1, R Lorenzini, R Verticchio, L Agatensi, A Cassone.   

Abstract

Candida parapsilosis was isolated from the vaginas of several nonpregnant, nondiabetic, mostly premenopausal outpatients who presented the characteristic signs and symptoms of a frank vulvovaginal candidiasis (heavy discharge with cottage cheese appearance and intense itching, with or without vulvar erythema and dyspareunia). All isolates conformed morphologically, biochemically, and serologically to the standard description of the species. They showed high acid proteinase-secretory activity in vitro and were appreciably pathogenic for cyclophosphamide-immunodepressed mice. Some isolates were also tested for their vaginopathic potential in ovariectomized rats under estradiol administration. In all cases, the rat vagina was colonized by C. parapsilosis to an extent and duration not different from those caused by a vaginopathic isolate of Candida albicans. Periodic acid-Schiff-stained vaginal smears taken at intervals during rat experimental infection showed C. parapsilosis yeasts adhering to exfoliated epithelial cells of rat vagina. Overall, these results emphasize the proteolytic and pathogenic potential of C. parapsilosis and suggest that this fungus may be an agent of clinical vaginitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681258      PMCID: PMC267083          DOI: 10.1128/jcm.27.11.2598-2603.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Microflora of the vagina during pregnancy.

Authors:  R Hurley; V C Stanley; B G Leask; J De Louvois
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1974

Review 2.  Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

3.  Genetic evidence for role of extracellular proteinase in virulence of Candida albicans.

Authors:  K J Kwon-Chung; D Lehman; C Good; P T Magee
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

4.  Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans.

Authors:  M Ghannoum; K Abu Elteen
Journal:  J Med Vet Mycol       Date:  1986-10

5.  Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of the enzyme during infection in vitro.

Authors:  R Rüchel; B Böning; M Borg
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Hormonal factors in vaginal candidiasis in rats.

Authors:  O S Kinsman; A E Collard
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

7.  Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis.

Authors:  F C Odds; C E Webster; P Mayuranathan; P D Simmons
Journal:  J Med Vet Mycol       Date:  1988

8.  A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; G Sbaraglia; S Perito; A Cassone
Journal:  Sabouraudia       Date:  1984

9.  Importance of differential diagnosis in acute vaginitis.

Authors:  R L Sweet
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

10.  A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors.

Authors:  S S Witkin; J Hirsch; W J Ledger
Journal:  Am J Obstet Gynecol       Date:  1986-10       Impact factor: 8.661

View more
  17 in total

1.  Activation of the plasma kallikrein-kinin system by Candida albicans proteinase.

Authors:  H Kaminishi; M Tanaka; T Cho; H Maeda; Y Hagihara
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

2.  DNA fingerprinting and electrophoretic karyotype of environmental and clinical isolates of Candida parapsilosis.

Authors:  G Carruba; E Pontieri; F De Bernardis; P Martino; A Cassone
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

Review 3.  Nonculture methods for diagnosis of disseminated candidiasis.

Authors:  E Reiss; C J Morrison
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

Review 4.  Candida parapsilosis Vaginal Infection-a New Site of Azole Drug Resistance.

Authors:  J D Sobel; S Suprapaneni
Journal:  Curr Infect Dis Rep       Date:  2018-08-27       Impact factor: 3.725

Review 5.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Candidiasis visualised by proteinase-directed immunofluorescence.

Authors:  R Rüchel; F Zimmermann; B Böning-Stutzer; U Helmchen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis.

Authors:  Andrew M Borman; Christopher J Linton; Debra Oliver; Michael D Palmer; Adrien Szekely; Frank C Odds; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

8.  Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection.

Authors:  F De Bernardis; D Adriani; R Lorenzini; E Pontieri; G Carruba; A Cassone
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases.

Authors:  J F Alderete; E Newton; C Dennis; K A Neale
Journal:  Genitourin Med       Date:  1991-12

10.  Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis.

Authors:  F De Bernardis; A Cassone; J Sturtevant; R Calderone
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.